Video

Data Analytics in Specialty Pharmacy

Author(s):

Lauren Santye, Assistant Editor

John Campo, vice president of Specialty Pharmacy Trade Relations and Contracting at Managed Health Care Associates, discusses optimal use of data analytics in specialty pharmacy.

John Campo, vice president of Specialty Pharmacy Trade Relations and Contracting at Managed Health Care Associates, discusses optimal use of data analytics in specialty pharmacy.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Image Credit: shidlovski | stock.adobe.com
Related Content
Illustration from research for genomic medicine or gene therapy.
September 11th 2025

Navigating the Complex Landscape of Sickle Cell Gene Therapy: Operational Challenges and Collaborative Solutions

Luke Halpern, Assistant Editor
Pharmacy Focus: Role of Pharmacists in Proper Inhaler Usage
September 11th 2025

Pharmacy Focus: Role of Pharmacists in Proper Inhaler Usage

Jennifer Griffin, PharmD, MS Luke Halpern, Assistant Editor
Buprenorphine Rx medical pills in plastic bottle with tablets. Pills spilling out from yellow container. | Image Credit: luchschenF | stock.adobe.com
September 11th 2025

The Evolving Role of Retail Pharmacies in Expanding Buprenorphine Access

Danielle Valletti, Assistant Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
September 11th 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Oral metformin tablets (CKD) -- Image credit: Sherry Young | stock.adobe.com
September 11th 2025

Metformin, Potential Treatment for ADPKD, Currently Undergoing Investigation in Long-Term Efficacy Trial

Gillian McGovern, Associate Editor
Skin disorder, pepper appearance from scleroderma, autoimmune disease male hand Skin disorder pepper appearance from vitiligo,scleroderma raynaud, medical concept autoimmune disease.
September 11th 2025

Patients With Systemic Sclerosis Face Decreased HDL-C, Increased Lipoprotein(a)

Luke Halpern, Assistant Editor
© 2025 MJH Life Sciences

All rights reserved.